{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:35:54Z","timestamp":1791462954893,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bmcl.2024.129675","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T05:02:04Z","timestamp":1709096524000},"page":"129675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8016-8369","authenticated-orcid":false,"given":"George","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusty","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitriyee","family":"Mahanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-046X","authenticated-orcid":false,"given":"Sarah","family":"Tronnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Cowdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Spasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-6023","authenticated-orcid":false,"given":"Rebecca","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Marleaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga V.","family":"Hochheiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-5002","authenticated-orcid":false,"given":"Matthias","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Fortney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wilhelmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129675_b0005","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmcl.2024.129675_b0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2024.129675_b0015","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s42003-022-04120-2","article-title":"ATP-binding and hydrolysis of human NLRP3","volume":"5","author":"Brinkschulte","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.bmcl.2024.129675_b0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/JLB.3MR0720-513R","article-title":"NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma","volume":"108","author":"McKee","year":"2020","journal-title":"J Leukoc Bio"},{"key":"10.1016\/j.bmcl.2024.129675_b0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","article-title":"Cryo-EM structures of the active NLRP3 inflammasome disc","volume":"613","author":"Xiao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2024.129675_b0030","article-title":"Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation","volume":"8(19):eabn7583","author":"Hochheiser","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmcl.2024.129675_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2024.129675_b0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","article-title":"CAPS and NLRP3","volume":"39","author":"Booshehri","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bmcl.2024.129675_b0045","first-page":"68","article-title":"Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950","volume":"73","author":"Corcoran","year":"2021","journal-title":"Pharacol Rev"},{"key":"10.1016\/j.bmcl.2024.129675_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.643254","article-title":"Neurodegenerative disease and the NLRP3 inflammasome","volume":"12","author":"Holbrook","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129675_b0055","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2024.129675_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111822","article-title":"Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases","volume":"185","author":"Zhang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129675_b0065","unstructured":"McBride, C., Trzoss, L., Povero, D., et al., Overcoming preclinical safety obstacles to discover (S)-N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide (GDC-2394): a potent and selective NLRP3 inhibitor. https;\/\/doi.org\/10.1021\/acs.jmedchem.2c01250."},{"key":"10.1016\/j.bmcl.2024.129675_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129675_b0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmcl.2024.129675_b0080","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2024.129675_b0085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41573-023-00713-6","article-title":"Small-molecule discovery through DNA-encoded libraries","volume":"22","author":"Peterson","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2024.129675_b0090","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/acs.jmedchem.2c01886","article-title":"Discovery of highly potent and BMPR2-selective kinase inhibitors using DNA-encoded chemical library screening","volume":"66","author":"Modukuri","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129675_b0095","unstructured":"Li, A.S.M.; Kimani, S; Wilson, B.; Noureldin, M.; Ivarez, H.G.; Mamai, A.; Hoffer, L.; Guilinger, J.P.; Zhang, Y.; von Rechenberg, M.; disch, J.S.; Mulhern, C.J.; Slakman, B.L.; Cuozzo, J.W.; Dong, A.; Poda, G.; Mohanned, M.; Saraon, P.; Mittal, M.; ModH, P.; Rathod, V.; Patel, R.; Ackloo, S.; Santhakumr, V.; Szewczyk, M.M.; Barsyte-Lovejoy, D.; Arrowsmith, C.H.; Marcellus, R.; Buie, M-A.; Keefe, A.D. Brown, P.J.; Halabelian, L.; Al-awar,R.; Vedadi, M. Discovery of nanomolar DCAF1 small molecule ligands."},{"key":"10.1016\/j.bmcl.2024.129675_b0100","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmcl.2024.129675_b0105","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to Trat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bmcl.2024.129675_b0110","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.3390\/ijms21124294","article-title":"Cellular models and assays to study NLRP3 inflammasome biology","volume":"21","author":"Zito","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2024.129675_b0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1021\/acsmedchemlett.8b00047","article-title":"Why decreasing lipophilicity alone is not a reliable strategy for extending IV half-life","volume":"9","author":"Broccatelli","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129675_b0120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acsmedchemlett.8b00018","article-title":"Strategy for extending half-life in drug design and its significance","volume":"9","author":"Gunaydin","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129675_b0125","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/acs.jcim.7b00487","article-title":"Large-scale validation of mixed-solvent simulations to assess hotspots at protein-protein interaction interfaces","volume":"58","author":"Ghanakota","year":"2018","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2024.129675_b0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121353119","article-title":"Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation","volume":"119","author":"Ohto","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2024.129675_b0135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand \/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129675_b0140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the role of crystal packing forces in determining protein sidechain conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmcl.2024.129675_b0145","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006","journal-title":"Proc ACM\/IEEE Conf Super"},{"key":"10.1016\/j.bmcl.2024.129675_b0150","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.1136800","article-title":"Clustering by passing messages between data points","volume":"315","author":"Frey","year":"2007","journal-title":"Science"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:50:04Z","timestamp":1760773804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"alternative-id":["S0960894X24000775"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129675","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129675"}}